These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 16099410)
1. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery. Abmayr S; Gregorevic P; Allen JM; Chamberlain JS Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410 [TBL] [Abstract][Full Text] [Related]
2. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500 [TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Athanasopoulos T; Graham IR; Foster H; Dickson G Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557 [TBL] [Abstract][Full Text] [Related]
5. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597 [TBL] [Abstract][Full Text] [Related]
6. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Schertzer JD; Ryall JG; Lynch GS Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899 [TBL] [Abstract][Full Text] [Related]
16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
17. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice. Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887 [TBL] [Abstract][Full Text] [Related]
19. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Karpati G; Acsadi G Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366 [TBL] [Abstract][Full Text] [Related]
20. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Liu F; Nishikawa M; Clemens PR; Huang L Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]